Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
L-tyrosine + O2 + AH2
L-dopa + H2O + A
radioactive substrate L-[3,5-3H]-tyrosine, specific activity 50 Ci/mmol
-
-
?
2,4,5-trihydroxyphenethylamine + O2
?
-
-
-
-
?
3,4,5-trihydroxyphenethylamine + O2
?
-
-
-
-
r
3,4,6-trihydroxyphenylalanine + O2
?
-
-
-
-
?
3,4-dihydroxyphenethylamine + O2
?
-
-
-
-
?
3,4-dihydroxyphenylalanine methyl ester + O2
?
-
-
-
-
?
3,4-dihydroxyphenylethanol + O2
2-(3,4-dioxocyclohexa-1,5-dien-1-yl)ethanol + H2O
-
-
-
-
r
3,4-dihydroxyphenylglycol + O2
2-(3,4-dioxocyclohexa-1,5-dien-1-yl)glycol + H2O
-
-
-
-
r
3,4-dihydroxyphenylserine + O2
?
-
-
-
-
?
3-(3,4-dihydroxyphenyl)-2-methylalanine + O2
?
-
-
-
-
?
4-methylcatechol + O2
4-methyl-o-benzoquinone + H2O
D-dopa + O2
dopaquinone + H2O
-
-
-
-
r
DL-DOPA + O2
dopaquinone + H2O
-
-
-
-
r
dopa + 1/2 O2
dopaquinone + H2O
L-3,4-dihydroxyphenylalanine + 1/2 O2
L-dopaquinone + H2O
-
-
-
-
?
L-dopa + 1/2 O2
dopachrome + H2O
-
-
-
-
?
L-dopa + 1/2 O2
L-dopaquinone + H2O
-
-
-
-
?
L-tyrosine + L-dopa + O2
L-dopa + dopaquinone + H2O
-
-
-
-
?
L-tyrosine + O2
L-DOPA + H2O
-
-
-
-
?
L-tyrosine + O2 + AH2
L-3,4-dihydroxyphenylalanine + H2O + A
N-acetyl-3,4-dihydroxyphenethylamine + O2
?
-
-
-
-
?
N-methyl-3,4-dihydroxyphenethylamine + O2
?
-
-
-
-
?
additional information
?
-
-
catalyzing the rate-limiting step for melanin biosynthesis
-
-
?
4-methylcatechol + O2
4-methyl-o-benzoquinone + H2O
-
-
-
?
4-methylcatechol + O2
4-methyl-o-benzoquinone + H2O
-
-
-
?
4-methylcatechol + O2
4-methyl-o-benzoquinone + H2O
-
-
-
?
4-methylcatechol + O2
4-methyl-o-benzoquinone + H2O
-
-
-
?
4-methylcatechol + O2
4-methyl-o-benzoquinone + H2O
-
-
-
?
dopa + 1/2 O2
dopaquinone + H2O
-
-
-
-
?
dopa + 1/2 O2
dopaquinone + H2O
-
L-dopa
-
?
L-tyrosine + O2 + AH2
L-3,4-dihydroxyphenylalanine + H2O + A
-
-
-
-
?
L-tyrosine + O2 + AH2
L-3,4-dihydroxyphenylalanine + H2O + A
-
rate-limiting enzyme in melanin biosynthesis
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(2E)-3-(3,4-dihydroxyphenyl)-N-[2-(1H-indol-3-yl)ethyl]prop-2-enamide
(2E)-3-(3,4-dihydroxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide
(2E)-3-(3,4-dihydroxyphenyl)-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]prop-2-enamide
(2E)-3-(3,4-dihydroxyphenyl)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]prop-2-enamide
(2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(1H-indol-3-yl)ethyl]prop-2-enamide
(2E)-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamide
1-(2,4-dihydroxyphenyl)-3-(2,4-dimethoxy-3-methylphenyl)propane
-
tyrosinase inhibitor with strong depigmenting effects, found in the medicinal plant Dianella ensifolia. 22times more potent than kojic acid
2,4-dihydroxy-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]benzamide
2-butyl-5-hydroxyphenyl 3-(3,4-dihydroxyphenyl)propanoate
-
KI-063
3,4-dihydroxy-N-[2-(1H-indol-3-yl)ethyl]benzamide
3,4-dihydroxy-N-[2-(4-hydroxyphenyl)ethyl]benzamide
3,4-dihydroxy-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]benzamide
3-(2-aminoethyl)-1H-indol-5-ol
4-hydroxy-N-[2-(1H-indol-3-yl)ethyl]benzamide
-
0% inhibition at 0.1 mM
4-hydroxy-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-3-methoxybenzamide
4-hydroxy-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]benzamide
gallic acid
-
significantly inhibited tyrosinase. Isolated from Radix polygoni multiflori, a herb used effectively to prevent graying and to treat skin depigmentation diseases in traditional Chinese medicine
N-caffeoylserotonin
-
73% inhibition at 0.1 mM
N-protocatechuoylserotonin
-
48% inhibition at 0.1 mM
N-[2-(1H-indol-3-yl)ethyl]benzamide
N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]acetamide
N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]benzamide
p-hydroxybenzyl alcohol
-
p-hydroxybenzyl alcohol, inhibitory effect on tyrosinase activity and melanogenesis. p-hydroxybenzyl alcohol exhibits an inhibitory effect on melanogenesis in mouse melanocytes at noncytotoxic concentrations. The results indicate that no significant difference is observed in tyrosinase gene expression between the p-hydroxybenzyl alcohol-treated and non-treated cells. Thus, it is concluded that no repression of tyrosinase gene is induced by p-hydroxybenzyl alcohol
paeonol
-
effects of paeonol on cell growth of B16F10 melanoma cells are shown. The effect of a high dose of paeonol (200 microM) is better than that of 2 microM hydroquinone (HQ), which acts as a positive agent. Paeonol down-regulates tyrosinase expression at mRNA and protein level. And paeonol inhibits MITF mRNA expression in B16F10 melanoma cells und the phosphorylation of CREB
terrein
-
examines the effects of a combination of 2-butyl-5-hydroxyphenyl 3-(3,4-dihydroxyphenyl)propanoate with terrein, an agent that down-regulates microphthalmia-associated transcription factor. Cells co-treated with 2-butyl-5-hydroxyphenyl 3-(3,4-dihydroxyphenyl)propanoate and terrein show much less pigmentation than cells treated with 2-butyl-5-hydroxyphenyl 3-(3,4-dihydroxyphenyl)propanoate or terrein alone
(2E)-3-(3,4-dihydroxyphenyl)-N-[2-(1H-indol-3-yl)ethyl]prop-2-enamide
-
14% inhibition at 0.1 mM
(2E)-3-(3,4-dihydroxyphenyl)-N-[2-(1H-indol-3-yl)ethyl]prop-2-enamide
-
2% inhibition at 0.1 mM
(2E)-3-(3,4-dihydroxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide
-
30% inhibition at 0.1 mM
(2E)-3-(3,4-dihydroxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide
-
15% inhibition at 0.1 mM
(2E)-3-(3,4-dihydroxyphenyl)-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]prop-2-enamide
-
73% inhibition at 0.1 mM
(2E)-3-(3,4-dihydroxyphenyl)-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]prop-2-enamide
-
55% inhibition at 0.1 mM
(2E)-3-(3,4-dihydroxyphenyl)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]prop-2-enamide
-
4% inhibition at 0.1 mM
(2E)-3-(3,4-dihydroxyphenyl)-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]prop-2-enamide
-
1% inhibition at 0.1 mM
(2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(1H-indol-3-yl)ethyl]prop-2-enamide
-
4% inhibition at 0.1 mM
(2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(1H-indol-3-yl)ethyl]prop-2-enamide
-
13% inhibition at 0.1 mM
(2E)-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamide
-
29% inhibition at 0.1 mM
(2E)-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamide
-
48% inhibition at 0.1 mM
1H-indol-5-ol
-
54% inhibition at 0.1 mM
1H-indol-5-ol
-
62% inhibition at 0.1 mM
2,4-dihydroxy-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]benzamide
-
50% inhibition at 0.1 mM
2,4-dihydroxy-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]benzamide
-
39% inhibition at 0.1 mM
3,4-dihydroxy-N-[2-(1H-indol-3-yl)ethyl]benzamide
-
7% inhibition at 0.1 mM
3,4-dihydroxy-N-[2-(1H-indol-3-yl)ethyl]benzamide
-
2% inhibition at 0.1 mM
3,4-dihydroxy-N-[2-(4-hydroxyphenyl)ethyl]benzamide
-
6% inhibition at 0.1 mM
3,4-dihydroxy-N-[2-(4-hydroxyphenyl)ethyl]benzamide
-
9% inhibition at 0.1 mM
3,4-dihydroxy-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]benzamide
-
43% inhibition at 0.1 mM
3,4-dihydroxy-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]benzamide
-
48% inhibition at 0.1 mM
3-(2-aminoethyl)-1H-indol-5-ol
-
15% inhibition at 0.1 mM
3-(2-aminoethyl)-1H-indol-5-ol
-
22% inhibition at 0.1 mM
4-hydroxy-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-3-methoxybenzamide
-
16% inhibition at 0.1 mM
4-hydroxy-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-3-methoxybenzamide
-
32% inhibition at 0.1 mM
4-hydroxy-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]benzamide
-
9% inhibition at 0.1 mM
4-hydroxy-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]benzamide
-
31% inhibition at 0.1 mM
kojic acid
-
-
kojic acid
-
55% inhibition at 0.1 mM
N-[2-(1H-indol-3-yl)ethyl]benzamide
-
1% inhibition at 0.1 mM
N-[2-(1H-indol-3-yl)ethyl]benzamide
-
0% inhibition at 0.1 mM
N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]acetamide
-
18% inhibition at 0.1 mM
N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]acetamide
-
23% inhibition at 0.1 mM
N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]benzamide
-
22% inhibition at 0.1 mM
N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]benzamide
-
23% inhibition at 0.1 mM
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Terao, M.; Tabe, L.; Garattini, E.; Sartori, D.; Studer, M.; Mintz, B.
Isolation and characterization of variant cDNAs encoding mouse tyrosinase
Biochem. Biophys. Res. Commun.
159
848-853
1989
Mus musculus
brenda
Yurkow, E.J.; Laskin, J.D.
Purification of tyrosinase to homogeneity based on its resistance to sodium dodecyl sulfate-proteinase K digestion
Arch. Biochem. Biophys.
275
122-129
1989
Mus musculus
brenda
Jimenez, M.; Maloy, W.L.; Hearing, V.J.
Specific identification of an authentic clone for mammalian tyrosinase
J. Biol. Chem.
264
3397-3403
1989
Mus musculus
brenda
Takeuchi, S.; Yamamoto, H.; Takeuchi, T.
Expression of tyrosinase gene in amelanotic mutant mice
Biochem. Biophys. Res. Commun.
155
470-475
1988
Mus musculus
brenda
Hearing, V.J.
Mammalian monophenol monooxygenase (tyrosinase): purification, properties, and reactions catalyzed
Methods Enzymol.
142
154-165
1987
Mammalia, Mus musculus
brenda
Menon, I.A.; Haberman, H.F.
Activation of tyrosinase in microsomes and melanosomes from B16 and Harding-Passey melanomas
Arch. Biochem. Biophys.
137
231-242
1970
Mus musculus
brenda
Yamamoto, H.; Takeuchi, S.; Kudo, T.; Makino, K.; Nakata, A.; Shinoda, T.; Takeuchi, T.
Cloning and sequencing of mouse tyrosinase cDNA
Jpn. J. Genet.
62
271-274
1987
Mus musculus
-
brenda
Hearing, V.J.; Ekel, T.M.; Montague, P.M.; Hearing, E.D.; Nicholson, J.M.
Mammalian tyrosinase: isolation by a simple new procedure and characterization of its steric requirements for cofactor activity
Arch. Biochem. Biophys.
185
407-418
1978
Mus musculus
brenda
Kwon, B.S.; Walkulchik, M.; Haq, A.K.; Halaban, R.; Kestler, D.
Sequence analysis of mouse tyrosinase cDNA and the effect of melanotropin on its gene expression
Biochem. Biophys. Res. Commun.
153
1301-1309
1988
Mus musculus
brenda
Muller, G.; Ruppert, S.; Schmid, E.; Schutz, G.
Functional analysis of alternatively spliced tyrosinase gene transcripts
EMBO J.
7
2723-2730
1988
Mus musculus
brenda
Fuller, B.B.; Lundsford, J.B.; Iman, D.S.
alpha-Melanocyte-stimulating hormone regulation of tyrosinase in Cloudman S-91 mouse melanoma cell cultures
J. Biol. Chem.
262
4024-4033
1987
Mus musculus
brenda
Jimenez-Cervantes, C.; Garcia-Borron, J.C.; Valverde, P.; Solano, F.; Lozano, J.A.
Tyrosinase isoenzymes in mammalian melanocytes. 1. Biochemical characterization of two melanosomal tyrosinases from B16 mouse melanoma
Eur. J. Biochem.
217
549-556
1993
Mus musculus
brenda
Jimenez-Cervantes, C.; Garcia-Borron, J.C.; Lozano, J.A.; Solano, F.
Effect of detergents and endogenous lipids on the activity and properties of tyrosinase and its related proteins
Biochim. Biophys. Acta
1243
421-430
1995
Mus musculus
brenda
Bu, J.; Ma, P.C.; Chen, Z.Q.; Zhou, W.Q.; Fu, Y.J.; Li, L.J.; Li, C.R.
Inhibition of MITF and tyrosinase by paeonol-stimulated JNK/SAPK to reduction of phosphorylated CREB
Am. J. Chin. Med.
36
245-263
2008
Mus musculus
brenda
Liu, S.H.; Pan, I.H.; Chu, I.M.
Inhibitory effect of p-hydroxybenzyl alcohol on tyrosinase activity and melanogenesis
Biol. Pharm. Bull.
30
1135-1139
2007
Agaricus bisporus, Mus musculus
brenda
Nesterov, A.; Zhao, J.; Minter, D.; Hertel, C.; Ma, W.; Abeysinghe, P.; Hong, M.; Jia, Q.
1-(2,4-dihydroxyphenyl)-3-(2,4-dimethoxy-3-methylphenyl)propane, a novel tyrosinase inhibitor with strong depigmenting effects
Chem. Pharm. Bull.
56
1292-1296
2008
Agaricus bisporus, Mus musculus
brenda
Guan, S.; Su, W.; Wang, N.; Li, P.; Wang, Y.
Effects of radix polygoni multiflori components on tyrosinase activity and melanogenesis
J. Enzyme Inhib. Med. Chem.
23
252-255
2008
Agaricus bisporus, Mus musculus
brenda
Kim, D.S.; Lee, S.; Lee, H.K.; Park, S.H.; Ryoo, I.J.; Yoo, I.D.; Kwon, S.B.; Baek, K.J.; Na, J.I.; Park, K.C.
The hypopigmentary action of KI-063 (a new tyrosinase inhibitor) combined with terrein
J. Pharm. Pharmacol.
60
343-348
2008
Agaricus bisporus, Mus musculus
brenda
Setty, S.R.; Tenza, D.; Sviderskaya, E.V.; Bennett, D.C.; Raposo, G.; Marks, M.S.
Cell-specific ATP7A transport sustains copper-dependent tyrosinase activity in melanosomes
Nature
454
1142-1146
2008
Mus musculus
brenda
Guan, S.; Su, W.; Wang, N.; Li, P.; Wang, Y.
A potent tyrosinase activator from Radix Polygoni multiflori and its melanogenesis stimulatory effect in B16 melanoma cells
Phytother. Res.
22
660-663
2008
Agaricus bisporus, Mus musculus
brenda
Schweikardt, T.; Olivares, C.; Solano, F.; Jaenicke, E.; Garcia-Borron, J.C.; Decker, H.
A three-dimensional model of mammalian tyrosinase active site accounting for loss of function mutations
Pigment Cell Res.
20
394-401
2007
Mus musculus (P11344), Mus musculus
brenda
Yamazaki, Y.; Kawano, Y.; Yamanaka, A.; Maruyama, S.
N-[(dihydroxyphenyl)acyl]serotonins as potent inhibitors of tyrosinase from mouse and human melanoma cells
Bioorg. Med. Chem. Lett.
19
4178-4182
2009
Homo sapiens, Mus musculus
brenda
Olivares, C.; Solano, F.
New insights into the active site structure and catalytic mechanism of tyrosinase and its related proteins
Pigment Cell Melanoma Res.
22
750-760
2009
Gallus gallus, Homo sapiens, Mus musculus, Streptomyces castaneoglobisporus
brenda